The Asia Pacific region is rapidly becoming a global force in healthcare and biotech innovation—fueled by resilient capital flows and propelled by its rising scientific capabilities, diverse patient populations, and growing appetite for cutting-edge solutions in precision medicine, digital health, and life sciences R&D. This panel will explore how the region’s ecosystems are uniquely positioned to tackle global health challenges and deliver scalable, patient-centric innovation. From Singapore’s translational research infrastructure to Japan’s aging population driving medtech advancement, and India’s data-rich environments accelerating AI diagnostics, panelists will discuss where Asia’s greatest healthcare opportunities lie. The conversation will also highlight the role of venture capital and strategic partnerships in catalyzing next-gen biotech and tech startups, and how multinational players have helped to establish the foundation for growth to shape the innovation landscape. This timely discussion offers a regional deep dive into what’s next for health innovation in Asia—and how pioneering scientists, company founders, investors, and ecosystem builders can contribute to its momentum. Sponsored by: Johnson & Johnson